Growth Metrics

Innoviva (INVA) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to 32.08%.

  • Innoviva's EBITDA Margin fell 162300.0% to 32.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.79%, marking a year-over-year decrease of 114800.0%. This contributed to the annual value of 2.19% for FY2024, which is 109400.0% down from last year.
  • As of Q3 2025, Innoviva's EBITDA Margin stood at 32.08%, which was down 162300.0% from 48.61% recorded in Q2 2025.
  • In the past 5 years, Innoviva's EBITDA Margin registered a high of 8265.41% during Q2 2021, and its lowest value of 1668.23% during Q1 2025.
  • For the 5-year period, Innoviva's EBITDA Margin averaged around 56.0%, with its median value being 489.64% (2022).
  • Per our database at Business Quant, Innoviva's EBITDA Margin surged by 81694100bps in 2021 and then plummeted by -87550600bps in 2022.
  • Over the past 5 years, Innoviva's EBITDA Margin (Quarter) stood at 611.53% in 2021, then crashed by -61bps to 982.68% in 2022, then skyrocketed by 56bps to 430.5% in 2023, then tumbled by -98bps to 853.36% in 2024, then surged by 104bps to 32.08% in 2025.
  • Its last three reported values are 32.08% in Q3 2025, 48.61% for Q2 2025, and 1668.23% during Q1 2025.